$600M in prizes drove $30B in R&D
XPRIZE has launched $600 million worth of prize competitions and catalyzed approximately $30 billion in R&D investment as a result.
Snapshot · Moonshots with Peter Diamandis
Michael Kratsios on the New Golden Age of American Science | EP #276
Explore episode
Aug 4, 2026
Where this was said
Prizes, XPRIZE, and the Future of Pay-for-Results Science
At 47:23 · chapter starts 45:55
With the Golden Age Report explicitly endorsing prize challenges and advanced market commitments, Peter steps into his home turf: over 30 years, XPRIZE has launched $600 million in prize competitions and driven approximately $30 billion in R&D — a roughly 50:1 leverage ratio on prize capital. He pitches Kratsios on the idea of 10 $1 billion prizes focused on the nation's most important challenges, including one targeting longevity. Kratsios is enthusiastic but pragmatic: the federal budget can absorb prizes in the $100 million range for sufficiently significant challenges, but $1 billion for a single prize is a stretch for the current fiscal environment. Peter then introduces the $101 million XPRIZE Healthspan — the organization's largest-ever prize, with 830 competing teams — as an example of what's achievable, arguing that reversing aging by 20 functional years would be the single highest-impact intervention on the US economy.
XPRIZE and the Power of Prizes: $600M That Drove $30B in R&D
XPRIZE has launched $600 million in prizes and catalyzed $30 billion in R&D. The Golden Age Report explicitly endorses prize challenges, advanced market commitments, and pay-for-results models as alternatives to traditional grants — with the administration eyeing prizes in the $100 million range for major national challenges.
US spends ~$200B/year on R&D
The US federal government spends approximately $200 billion per year on R&D, with roughly $45 billion of that at NIH for biomedical research.
XPRIZE Healthspan: $101M, 830 teams
The XPRIZE Healthspan competition is a $101 million prize with 830 competing teams, aiming to reverse functional age by 20 years.
Similar snapshots
540M years ago: first animal vision
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
50% of cortex involved in vision
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Human 6-year-olds learn tens of thousands of object categories
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
~3% of FDA drugs have unclear mechanisms
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
30–50% of phase 1 drugs fail to reach phase 2
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
BPC-157 published work: >80% from one group
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
~100 approved peptide drugs; ~150 in trials
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
BPC-157 founder withheld screening method
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
Brain barely distinguishes imagined vs real
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
